Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Diabetes.”

6,487 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 6,487 results

Large-scale testing (Phase 3)Study completedNCT01730534
What this trial is testing

Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events

Who this might be right for
Diabetes Mellitus, Non-Insulin-DependentHigh Risk for Cardiovascular Event
AstraZeneca 17,190
Testing effectiveness (Phase 2)Study completedNCT00544206
What this trial is testing

Comparison of Enteral Products for Tube Fed Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Abbott Nutrition 11
Post-approval studies (Phase 4)Study completedNCT01927315
What this trial is testing

Effects of Fenofibrate on Endothelial Progenitor Cells in Diabetes

Who this might be right for
DiabetesDiabetic Retinopathy
University of Padova 41
Post-approval studies (Phase 4)UnknownNCT04739215
What this trial is testing

Effects of SGLT2 Inhibition on the Mechanisms of Cardiac Damage in the Diabetic Patient With HFpEF

Who this might be right for
Diabetes Mellitus, Type 2Heart Failure With Preserved Ejection Fraction
Hospital General Universitario Gregorio Marañon 62
Not applicableStudy completedNCT03807440
What this trial is testing

DIA_CENTRAL:T2D Treatment Pattern in Central Europe

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 4,083
Post-approval studies (Phase 4)Ended earlyNCT02048904
What this trial is testing

Use of Sitagliptin to Decrease Microalbuminuria

Who this might be right for
Type 2 DiabetesMicroalbuminuria
University of Missouri-Columbia 142
Not applicableStudy completedNCT00497133
What this trial is testing

Alpha-Cell Sensitivity to GLP-1 in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
University of Copenhagen 20
Testing effectiveness (Phase 2)Study completedNCT01969747
What this trial is testing

Empagliflozin add-on to Insulin in Type 1 Diabetes Mellitus Over 28 Days

Who this might be right for
Diabetes Mellitus, Type 1
Boehringer Ingelheim 75
Large-scale testing (Phase 3)Study completedNCT02294643
What this trial is testing

Study Design of 'Influence of Sarpogrelate in Patients With Renal Impairment or Diabetes Mellitus' Study

Who this might be right for
Coronary Artery DiseaseDiabetes MellitusRenal Insufficiency, Chronic
Seoul National University Bundang Hospital 220
Post-approval studies (Phase 4)WithdrawnNCT03042325
What this trial is testing

Safety and Efficacy of Alogliptin in Indian Participants With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Takeda
Not applicableUnknownNCT02874963
What this trial is testing

FM-SRP and Tooth Extraction Improve Type 2 Diabetes Mellitus in Periodontitis

Who this might be right for
PeriodontitisType 2 Diabetes Mellitus
University Clinical Centre of Kosova 160
Not applicableStudy completedNCT02848833
What this trial is testing

JARDIANCE Regulartory Post Marketing Surveillance in Korean Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 3,368
Not applicableUnknownNCT05196958
What this trial is testing

Interest of GLP1 Analogues in Overweight Type 2 Diabetic Patients With Chronic Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel DiseasesDiabetes Mellitus, Type 2
Fondation Hôpital Saint-Joseph 20
Large-scale testing (Phase 3)Ended earlyNCT04371978
What this trial is testing

Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19

Who this might be right for
COVID 19CoronavirusDiabetes Mellitus, Type 2+12 more
Rabin Medical Center 64
Testing effectiveness (Phase 2)Study completedNCT06849843
What this trial is testing

3mg Once Every Two Weeks Administration of Efsubaglutide Alfa Injection in Type 2 Diabetes Patients.

Who this might be right for
Type2 Diabetes
Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. 59
Not applicableNot Yet RecruitingNCT06066944
What this trial is testing

Effect of Thai Foot Massage on Type 2 Diabetes Peripheral Neuropathy

Who this might be right for
Peripheral Diabetic Neuropathy
University of Health Sciences Lahore 78
Not applicableUnknownNCT05103306
What this trial is testing

Empagliflozin-based Quadruple Therapy vs Basal Insulin-based Therapy

Who this might be right for
Diabetes Mellitus, Type 2
Chungbuk National University Hospital 300
Not applicableStudy completedNCT00237952
What this trial is testing

Environmental Exposure to Lead and Progressive Renal Insufficiency in Type II Diabetic Nephropathy

Who this might be right for
Diabetic NephropathiesDiabetes Mellitus, Type II
Chang Gung Memorial Hospital
Large-scale testing (Phase 3)Study completedNCT01531114
What this trial is testing

PraSugrel vs TicagrElor in ST-Elevation Myocardial Infarction paTients With Diabetes Mellitus

Who this might be right for
ST-Elevation Myocardial Infarction
Gennaro Sardella 50
Not applicableEnded earlyNCT05088616
What this trial is testing

Native American Diabetes Project

Who this might be right for
DiabetesDiabete Type 2Diabetes Mellitus, Type 1+3 more
University of Southern California 53
Next Page